/
IMUC
$0.27+$0.05 (+22.68%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.04 – $0.34
77% from low
Exchange
OTC Link
CS
Borrow rate
35.72%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-0.15
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2016 | 2017 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $75.1K | $47.8K | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross profit | −$75.1K | −$47.8K | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $19.1M | $17.1M | $696.7K | $1.3M | $1.2M | $580.9K | $937.0K | $843.8K |
| Operating income | −$24.1M | −$21.2M | −$1.5M | −$2.6M | −$2.9M | −$1.7M | −$2.0M | −$1.8M |
| EBITDA | −$20.2M | −$13.4M | $0 | −$1 | −$2.2M | −$999.3K | −$929.1K | −$1.8M |
| Net income | −$23.4M | −$18.5M | −$1.5M | −$2.7M | −$2.6M | −$1.6M | −$1.9M | −$1.9M |
| Net margin | — | — | — | — | — | — | — | — |
| EPS (diluted) | -83.60 | -4.42 | -0.03 | -0.06 | -0.02 | -0.01 | -0.02 | -0.02 |
Annual figures · source: Financial Modeling Prep
Peer comparison
EOM PHARMACEUTICAL HLDNGS
EOM PHARMACEUTICAL HLDNGS
Held by traders on TradeandTell
No one on the platform currently holds IMUC.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in IMUC as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2020-09-16 | 1-for-10reverse |
| 2016-11-21 | 1-for-40reverse |
Recent trades on TradeandTell
No one on the platform has traded IMUC yet.
